Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands

The Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA) demonstrated the efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) in preventing vaccine-type community-acquired pneumonia and vaccine-type invasive pneumococcal disease in elderly subjects. We examined the cost-effect...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Eur Respir J
Egile Nagusiak: Mangen, Marie-Josée J., Rozenbaum, Mark H., Huijts, Susanne M., van Werkhoven, Cornelis H., Postma, Douwe F., Atwood, Mark, van Deursen, Anna M.M., van der Ende, Arie, Grobbee, Diederick E., Sanders, Elisabeth A.M., Sato, Reiko, Verheij, Theo J.M., Vissink, Conrad E., Bonten, Marc J.M., de Wit, G. Ardine
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: European Respiratory Society 2015
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4750466/
https://ncbi.nlm.nih.gov/pubmed/26160871
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/13993003.00325-2015
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak